IPHA
Innate Pharma·NASDAQ
--
--(--)
--
--(--)
IPHA Filings
Filing Date
Form Description
Form Type
2026-03-26
Innate Pharma SA (IPHA) Q4 2025 Earnings Call Transcript
Earnings Call
2026-03-26 · Earnings Call
Innate Pharma SA (IPHA) Q4 2025 Earnings Call Transcript
2026-03-26
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Financials
2026-03-26 · Financials
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-03-19
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-03-19 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-03-04
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-03-04 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-02-18
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-02-18 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-02-06
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2026-02-06 ·
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2026-01-07
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-01-07 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-12-22
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-12-22 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-12-11
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-12-11 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-11-28
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-11-28 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
